INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 45h ago
HOUSE PTR5h ago
SEC 13F5h ago
ROBINHOOD CHAIN5h ago
Public company

GKOSGLAUKOS Corp

CIK 0001192448

EDGAR filingsOpen in network
Disclosed transactions60
Buys / sells0 / 25
Max Insider Score39
Connections8with evidence

GKOS · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
0
NT
Navratil TomasCHIEF DEVELOPMENT OFFICER
GKOSGLAUKOS Corp
Open-market sale · 10b5-1 plan
SELL$25K
167 sh
Sep 25, 2026Sep 28, 2026
traded Sep 25, 2026
+3dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 3841 · Surgical & Medical Instruments & Apparatus · Nov 4, 2026
  • ← Lobbied forevidence
    THORN RUN PARTNERSLDA Q2 2026 second quarter · Health issues, Medicare/Medicaid, Taxation · Aug 26, 2026
  • ← Insider ofevidence
    Gilliam Joseph EPRESIDENT & COO · Jan 23, 2026
  • ← Insider ofevidence
    Wen LeanaDirector · Jan 7, 2026
1
NT
Navratil TomasCHIEF DEVELOPMENT OFFICER
GKOSGLAUKOS Corp
Open-market sale · 10b5-1 plan
SELL
$168K
1,083 sh
Sep 25, 2026
Sep 28, 2026
traded Sep 25, 2026
+3d
SEC FORM 4

Evidence

0
NT
Navratil TomasCHIEF DEVELOPMENT OFFICER
GKOSGLAUKOS Corp
Open-market sale · 10b5-1 plan
SELL$35K
229 sh
Sep 25, 2026Sep 28, 2026
traded Sep 25, 2026
+3dSEC FORM 4

Evidence

0
NT
Navratil TomasCHIEF DEVELOPMENT OFFICER
GKOSGLAUKOS Corp
Open-market sale · 10b5-1 plan
SELL$21K
136 sh
Sep 25, 2026Sep 28, 2026
traded Sep 25, 2026
+3dSEC FORM 4

Evidence

0
NT
Navratil TomasCHIEF DEVELOPMENT OFFICER
GKOSGLAUKOS Corp
Open-market sale · 10b5-1 plan
SELL$688
4 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC FORM 4

Evidence

1
NT
Navratil TomasCHIEF DEVELOPMENT OFFICER
GKOSGLAUKOS Corp
Open-market sale · 10b5-1 plan
SELL$57K
345 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC FORM 4

Evidence

0
NT
Navratil TomasCHIEF DEVELOPMENT OFFICER
GKOSGLAUKOS Corp
Open-market sale · 10b5-1 plan
SELL$40K
234 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC FORM 4

Evidence

0
NT
Navratil TomasCHIEF DEVELOPMENT OFFICER
GKOSGLAUKOS Corp
Open-market sale · 10b5-1 plan
SELL$32K
191 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC FORM 4

Evidence

0
NT
Navratil TomasCHIEF DEVELOPMENT OFFICER
GKOSGLAUKOS Corp
Open-market sale · 10b5-1 plan
SELL$20K
120 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC FORM 4

Evidence

0
NT
Navratil TomasCHIEF DEVELOPMENT OFFICER
GKOSGLAUKOS Corp
Open-market sale · 10b5-1 plan
SELL$17K
103 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC FORM 4

Evidence

1
NT
Navratil TomasCHIEF DEVELOPMENT OFFICER
GKOSGLAUKOS Corp
Open-market sale · 10b5-1 plan
SELL$77K
460 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC FORM 4

Evidence

27
NT
Navratil TomasCHIEF DEVELOPMENT OFFICER
GKOSGLAUKOS Corp
Open-market sale
SELL$1.10M
6,091 sh
Aug 28, 2026Sep 1, 2026
traded Aug 28, 2026
+4dSEC FORM 4

Evidence

14
NT
Navratil TomasCHIEF DEVELOPMENT OFFICER
GKOSGLAUKOS Corp
Open-market sale
SELL$1,825
10 sh
Aug 28, 2026Sep 1, 2026
traded Aug 28, 2026
+4dSEC FORM 4

Evidence

27
NT
Navratil TomasCHIEF DEVELOPMENT OFFICER
GKOSGLAUKOS Corp
Open-market sale
SELL$1.38M
7,643 sh
Aug 28, 2026Sep 1, 2026
traded Aug 28, 2026
+4dSEC FORM 4

Evidence

15
GE
Gilliam Joseph EPRESIDENT & COO
GKOSGLAUKOS Corp
Option exercise
M$485K
10.0K sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC FORM 4

Evidence

17
GE
Gilliam Joseph EPRESIDENT & COO
GKOSGLAUKOS Corp
Option exercise
M—
20.0K sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC FORM 4

Evidence

17
GE
Gilliam Joseph EPRESIDENT & COO
GKOSGLAUKOS Corp
Option exercise
M—
20.0K sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC FORM 4

Evidence

39
GE
Gilliam Joseph EPRESIDENT & COO
GKOSGLAUKOS Corp
Open-market sale
SELL$5.00M
28.0K sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC FORM 4

Evidence

18
GE
Gilliam Joseph EPRESIDENT & COO
GKOSGLAUKOS Corp
Option exercise
M$1.10M
20.0K sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC FORM 4

Evidence

22
GE
Gilliam Joseph EPRESIDENT & COO
GKOSGLAUKOS Corp
Option exercise
M$1.10M
20.0K sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC FORM 4

Evidence

15
GE
Gilliam Joseph EPRESIDENT & COO
GKOSGLAUKOS Corp
Option exercise
M$485K
10.0K sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC FORM 4

Evidence

39
GE
Gilliam Joseph EPRESIDENT & COO
GKOSGLAUKOS Corp
Open-market sale
SELL$5.78M
32.0K sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC FORM 4

Evidence

17
GE
Gilliam Joseph EPRESIDENT & COO
GKOSGLAUKOS Corp
Option exercise
M—
10.0K sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC FORM 4

Evidence

17
GE
Gilliam Joseph EPRESIDENT & COO
GKOSGLAUKOS Corp
Option exercise
M—
10.0K sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC FORM 4

Evidence

23
TR
Thurman Alex R.SVP & CHIEF FINANCIAL OFFICER
GKOSGLAUKOS Corp
Open-market sale · 10b5-1 plan
SELL$3.60M
20.0K sh
Aug 7, 2026Aug 11, 2026
traded Aug 7, 2026
+4dSEC FORM 4

Evidence

9
TR
Thurman Alex R.SVP & CHIEF FINANCIAL OFFICER
GKOSGLAUKOS Corp
Option exercise · 10b5-1 plan
M$676K
20.0K sh
Aug 7, 2026Aug 11, 2026
traded Aug 7, 2026
+4dSEC FORM 4

Evidence

0
TR
Thurman Alex R.SVP & CHIEF FINANCIAL OFFICER
GKOSGLAUKOS Corp
Option exercise · 10b5-1 plan
M—
20.0K sh
Aug 7, 2026Aug 11, 2026
traded Aug 7, 2026
+4dSEC FORM 4

Evidence

5
NT
Navratil TomasCHIEF DEVELOPMENT OFFICER
GKOSGLAUKOS Corp
Tax withholding
F$69K
483 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC FORM 4

Evidence

8
GE
Gilliam Joseph EPRESIDENT & COO
GKOSGLAUKOS Corp
Tax withholding
F$151K
1,056 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC FORM 4

Evidence

1
NT
Navratil TomasCHIEF DEVELOPMENT OFFICER
GKOSGLAUKOS Corp
Open-market sale · 10b5-1 plan
SELL$201K
1,537 sh
Jun 16, 2026Jun 18, 2026
traded Jun 16, 2026
+2dSEC FORM 4

Evidence

13
TD
Torres DeniceDirector
GKOSGLAUKOS Corp
Grant or award
A—
1,878 sh
May 28, 2026Jun 1, 2026
traded May 28, 2026
+4dSEC FORM 4

Evidence

5
WL
Wen LeanaDirector
GKOSGLAUKOS Corp
Grant or award
A—
2,987 sh
May 28, 2026Jun 1, 2026
traded May 28, 2026
+4dSEC FORM 4

Evidence

9
WL
Wen LeanaDirector
GKOSGLAUKOS Corp
Grant or award
A—
1,878 sh
May 28, 2026Jun 1, 2026
traded May 28, 2026
+4dSEC FORM 4

Evidence

9
TD
Torres DeniceDirector
GKOSGLAUKOS Corp
Grant or award
A—
2,987 sh
May 28, 2026Jun 1, 2026
traded May 28, 2026
+4dSEC FORM 4

Evidence

13
TR
Thurman Alex R.SVP & CHIEF FINANCIAL OFFICER
GKOSGLAUKOS Corp
Option exercise · 10b5-1 plan
M$387K
10.0K sh
Apr 30, 2026May 4, 2026
traded Apr 30, 2026
+4dSEC FORM 4

Evidence

9
TR
Thurman Alex R.SVP & CHIEF FINANCIAL OFFICER
GKOSGLAUKOS Corp
Option exercise · 10b5-1 plan
M$387K
10.0K sh
Apr 30, 2026May 4, 2026
traded Apr 30, 2026
+4dSEC FORM 4

Evidence

19
TR
Thurman Alex R.SVP & CHIEF FINANCIAL OFFICER
GKOSGLAUKOS Corp
Open-market sale · 10b5-1 plan
SELL$1.40M
10.0K sh
Apr 30, 2026May 4, 2026
traded Apr 30, 2026
+4dSEC FORM 4

Evidence

33
WL
Wen LeanaDirector
GKOSGLAUKOS Corp
Open-market sale
SELL$244K
1,700 sh
May 1, 2026May 4, 2026
traded May 1, 2026
+3dSEC FORM 4

Evidence

4
NT
Navratil TomasCHIEF DEVELOPMENT OFFICER
GKOSGLAUKOS Corp
Open-market sale · 10b5-1 plan
SELL$144K
1,237 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC FORM 4

Evidence

4
NT
Navratil TomasCHIEF DEVELOPMENT OFFICER
GKOSGLAUKOS Corp
Open-market sale · 10b5-1 plan
SELL$73K
614 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC FORM 4

Evidence

1
NT
Navratil TomasCHIEF DEVELOPMENT OFFICER
GKOSGLAUKOS Corp
Open-market sale · 10b5-1 plan
SELL$3,847
32 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC FORM 4

Evidence

1
NT
Navratil TomasCHIEF DEVELOPMENT OFFICER
GKOSGLAUKOS Corp
Open-market sale · 10b5-1 plan
SELL$25K
210 sh
Apr 10, 2026Apr 14, 2026
traded Apr 10, 2026
+4dSEC FORM 4

Evidence

9
NT
Navratil TomasCHIEF DEVELOPMENT OFFICER
GKOSGLAUKOS Corp
Grant or award
A—
4,622 sh
Mar 25, 2026Mar 27, 2026
traded Mar 25, 2026
+2dSEC FORM 4

Evidence

13
GE
Gilliam Joseph EPRESIDENT & COO
GKOSGLAUKOS Corp
Grant or award
A—
17.8K sh
Mar 25, 2026Mar 27, 2026
traded Mar 25, 2026
+2dSEC FORM 4

Evidence

16
TR
Thurman Alex R.SVP & CHIEF FINANCIAL OFFICER
GKOSGLAUKOS Corp
Open-market sale · 10b5-1 plan
SELL$267K
2,511 sh
Mar 25, 2026Mar 27, 2026
traded Mar 25, 2026
+2dSEC FORM 4

Evidence

0
TR
Thurman Alex R.SVP & CHIEF FINANCIAL OFFICER
GKOSGLAUKOS Corp
Grant or award · 10b5-1 plan
A—
3,303 sh
Mar 25, 2026Mar 27, 2026
traded Mar 25, 2026
+2dSEC FORM 4

Evidence

3
TR
Thurman Alex R.SVP & CHIEF FINANCIAL OFFICER
GKOSGLAUKOS Corp
Grant or award · 10b5-1 plan
A—
8,228 sh
Mar 25, 2026Mar 27, 2026
traded Mar 25, 2026
+2dSEC FORM 4

Evidence

14
TR
Thurman Alex R.SVP & CHIEF FINANCIAL OFFICER
GKOSGLAUKOS Corp
Grant or award · 10b5-1 plan
A—
19.6K sh
Mar 25, 2025Mar 27, 2026
traded Mar 25, 2025
+367dSEC FORM 4

Evidence

0
TR
Thurman Alex R.SVP & CHIEF FINANCIAL OFFICER
GKOSGLAUKOS Corp
Grant or award · 10b5-1 plan
A—
20.5K sh
Mar 25, 2026Mar 27, 2026
traded Mar 25, 2026
+2dSEC FORM 4

Evidence

9
NT
Navratil TomasCHIEF DEVELOPMENT OFFICER
GKOSGLAUKOS Corp
Grant or award
A—
11.7K sh
Mar 25, 2026Mar 27, 2026
traded Mar 25, 2026
+2dSEC FORM 4

Evidence

5
NT
Navratil TomasCHIEF DEVELOPMENT OFFICER
GKOSGLAUKOS Corp
Grant or award
A—
3,692 sh
Mar 25, 2026Mar 27, 2026
traded Mar 25, 2026
+2dSEC FORM 4

Evidence

9
NT
Navratil TomasCHIEF DEVELOPMENT OFFICER
GKOSGLAUKOS Corp
Grant or award
A—
12.8K sh
Mar 25, 2026Mar 27, 2026
traded Mar 25, 2026
+2dSEC FORM 4

Evidence

9
GE
Gilliam Joseph EPRESIDENT & COO
GKOSGLAUKOS Corp
Grant or award
A—
5,829 sh
Mar 25, 2026Mar 27, 2026
traded Mar 25, 2026
+2dSEC FORM 4

Evidence

13
GE
Gilliam Joseph EPRESIDENT & COO
GKOSGLAUKOS Corp
Grant or award
A—
16.5K sh
Mar 25, 2026Mar 27, 2026
traded Mar 25, 2026
+2dSEC FORM 4

Evidence

17
GE
Gilliam Joseph EPRESIDENT & COO
GKOSGLAUKOS Corp
Grant or award
A—
22.0K sh
Mar 25, 2026Mar 27, 2026
traded Mar 25, 2026
+2dSEC FORM 4

Evidence

5
GE
Gilliam Joseph EPRESIDENT & COO
GKOSGLAUKOS Corp
Grant or award
A—
36.8K sh
Mar 25, 2026Mar 27, 2026
traded Mar 25, 2026
+2dSEC FORM 4

Evidence

9
BW
Burns Thomas WilliamDirector, CHAIRMAN & CEO
GKOSGLAUKOS Corp
Grant or award
A—
9,380 sh
Mar 25, 2026Mar 27, 2026
traded Mar 25, 2026
+2dSEC FORM 4

Evidence

13
BW
Burns Thomas WilliamDirector, CHAIRMAN & CEO
GKOSGLAUKOS Corp
Grant or award
A—
14.2K sh
Mar 25, 2026Mar 27, 2026
traded Mar 25, 2026
+2dSEC FORM 4

Evidence

29
BW
Burns Thomas WilliamDirector, CHAIRMAN & CEO
GKOSGLAUKOS Corp
Grant or award
A$358.46M
18.9K sh
Mar 25, 2026Mar 27, 2026
traded Mar 25, 2026
+2dSEC FORM 4

Evidence

21
BW
Burns Thomas WilliamDirector, CHAIRMAN & CEO
GKOSGLAUKOS Corp
Grant or award
A$12.16B
110.3K sh
Mar 25, 2026Mar 27, 2026
traded Mar 25, 2026
+2dSEC FORM 4

Evidence

  • ← Insider ofevidence
    Torres DeniceDirector · Jan 7, 2026
  • ← Insider ofevidence
    Burns Thomas WilliamDirector, CHAIRMAN & CEO · Dec 31, 2025
  • ← Insider ofevidence
    Navratil TomasCHIEF DEVELOPMENT OFFICER · Dec 15, 2025
  • ← Insider ofevidence
    Thurman Alex R.SVP & CHIEF FINANCIAL OFFICER · Nov 26, 2025

    • Lobbying

    $520K reported · de-duplicated
    2026 Q2 $240K in-house2026 Q1 $280K in-house
    • In-house report$280K2026 Q1 · posted Aug 26, 2026 · Medicare/Medicaid, MED
    • THORN RUN PARTNERS$20K2026 Q1 · posted Aug 26, 2026 · Health issues, Medicare/Medicaid, Taxation
    • THORN RUN PARTNERS$20K2026 Q2 · posted Aug 26, 2026 · Health issues, Medicare/Medicaid, Taxation
    • In-house report$240K2026 Q2 · posted Aug 26, 2026 · MED, Medicare/Medicaid

    Connected PAC contributions

    FEC · direct to members

    No contributions from a PAC connected to this company.